Advisor Group Holdings, Inc. Biocryst Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 13,216 shares of BCRX stock, worth $100,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,216

Previous 5,517 139.55%

Holding current value

$100,045

Previous $34,000 194.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $49,350 - $66,904	7,699 Added 139.55%	13,216 $100,000
Q2 2024 Aug 13, 2024	SELL	$4.13 - $6.79 $3.08 Million - $5.06 Million	-745,177 Reduced 99.27%	5,517 $34,000
Q1 2024 May 10, 2024	BUY	$4.89 - $7.65 $281,981 - $441,137	57,665 Added 8.32%	750,694 $3.81 Million
Q4 2023 Feb 12, 2024	BUY	$4.98 - $6.77 $217,680 - $295,923	43,711 Added 6.73%	693,029 $4.15 Million
Q3 2023 Nov 13, 2023	BUY	$6.71 - $7.92 $310,196 - $366,133	46,229 Added 7.67%	649,318 $4.6 Million
Q2 2023 Aug 10, 2023	BUY	$6.96 - $8.81 $285,554 - $361,456	41,028 Added 7.3%	603,089 $4.25 Million
Q1 2023 May 12, 2023	SELL	$7.94 - $11.84 $46,504 - $69,346	-5,857 Reduced 1.03%	562,061 $4.69 Million
Q4 2022 Feb 10, 2023	SELL	$10.5 - $14.2 $59,419 - $80,357	-5,659 Reduced 0.99%	567,918 $6.52 Million
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $142,751 - $195,936	-13,230 Reduced 2.25%	573,577 $7.23 Million
Q2 2022 Aug 10, 2022	BUY	$7.89 - $17.88 $99,082 - $224,537	12,558 Added 2.19%	586,807 $6.21 Million
Q1 2022 May 04, 2022	BUY	$11.56 - $19.76 $748,856 - $1.28 Million	64,780 Added 12.72%	574,249 $9.34 Million
Q3 2021 Nov 05, 2021	BUY	$14.21 - $17.65 $1.33 Million - $1.65 Million	93,624 Added 22.51%	509,469 $7.32 Million
Q2 2021 Aug 02, 2021	BUY	$9.5 - $17.24 $257,906 - $468,031	27,148 Added 6.98%	415,845 $6.58 Million
Q1 2021 May 13, 2021	BUY	$7.37 - $13.61 $544,370 - $1.01 Million	73,863 Added 23.46%	388,697 $3.95 Million
Q4 2020 Feb 10, 2021	BUY	$3.37 - $8.61 $506,312 - $1.29 Million	150,241 Added 91.28%	314,834 $2.35 Million
Q3 2020 Nov 12, 2020	BUY	$3.43 - $5.53 $225,508 - $363,575	65,746 Added 66.51%	164,593 $565,000
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $138,935 - $410,225	73,124 Added 284.27%	98,847 $471,000
Q1 2020 May 18, 2020	BUY	$1.6 - $4.11 $41,156 - $105,721	25,723 New	25,723 $51,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Biocryst Pharmaceuticals Inc Transaction History